Ecolab Inc.

(New York Stock Exchange)
Back to all articles
Bullish +72

Ecolab stock outlook firms after strong third-quarter execution

Company update Earnings report AI-generated analysis

📈 Ecolab third-quarter sales rose 13 percent to $4.69 billion, with organic sales growth accelerating to 7 percent.

💰 Organic operating income grew 11 percent to $872.1 million, expanding the organic operating margin to 19.6 percent.

🎯 Management forecasts 2027 organic sales growth at the upper end of its 5-7 percent target range with a 20 percent adjusted operating margin.

🚀 Global High-Tech segment achieved exceptional organic sales growth of 63 percent in the third quarter.

🔬 Life Sciences organic sales increased 17 percent, demonstrating strength in the healthcare sector.

🤝 Acquisitions Ovivo Electronics and CoolIT are performing strongly and expected to add two percentage points to annual organic growth.

💵 Reported diluted earnings per share increased 5 percent to $2.18 despite a headwind from acquisition-related costs.

📅 Full-year 2026 adjusted EPS guidance is set between $8.10 and $8.20, representing 8-9 percent growth.

🔮 CEO Christophe Beck expects adjusted earnings growth to accelerate in the second half of 2027 as acquisition effects fade.

⚖️ Pricing and productivity gains successfully offset higher commodity costs and growth investments during the quarter.

Bullish Signals
  • Ecolab third-quarter sales increased 13 percent year-over-year to $4.69 billion, demonstrating strong top-line execution.
  • Organic operating margin expanded significantly to 19.6 percent as pricing and productivity gains offset higher costs.
  • Global High-Tech organic sales surged 63 percent, highlighting a major growth driver for the company.
  • Life Sciences organic sales grew 17 percent, reinforcing the strength of the healthcare portfolio.
  • Acquisitions Ovivo Electronics and CoolIT are performing strongly and will contribute two percentage points to annual organic growth.
  • Management raised expectations for 2027, targeting the upper end of the 5-7 percent organic sales growth range.
  • Adjusted diluted earnings per share rose 5 percent to $2.18, reflecting underlying business improvement.
  • The company maintains a long-term adjusted earnings growth target of 12-15 percent, supported by current execution.
Risk Factors
  • Reported diluted earnings per share fell 5 percent to $1.95 due to acquisition-related amortization and financing costs.
  • Net income attributable to Ecolab declined 6 percent to $551.3 million, impacted by non-organic factors.
  • Reported gross margin declined to 44.1 percent from 44.8 percent a year earlier due to acquisition integration profiles.
  • Acquisition-related amortization and financing costs currently create an approximately 10 percent headwind to earnings.
  • Investors will need to monitor the pace of CoolIT integration and whether it meets performance expectations.
Full Analysis
Ecolab Inc. reported a strong third-quarter performance characterized by significant sales growth and margin expansion, marking an inflection point for the water and hygiene specialist. Third-quarter sales increased 13 percent year-over-year to $4.69 billion, driven by volume growth of 2 percent and pricing acceleration of 5 percent. Organic sales growth accelerated to 7 percent, while organic operating income grew 11 percent, expanding the organic operating margin to 19.6 percent. Management provided updated guidance for fiscal year 2027, projecting organic sales growth at the upper end of its 5 percent to 7 percent target range and an adjusted operating margin of 20 percent. The company expects pricing and productivity gains to continue offsetting higher commodity costs and investments in acquisitions. CEO Christophe Beck highlighted that acquisition-related amortization and financing costs currently create a headwind, but these effects are expected to diminish in the second half of 2027. Specific business segments showed robust growth, with Global High-Tech organic sales surging 63 percent and Life Sciences organic sales increasing 17 percent. Key acquisitions Ovivo Electronics and CoolIT are performing strongly and are projected to contribute approximately two percentage points to annual organic sales growth within one year of closing. For the full year 2026, Ecolab expects adjusted diluted earnings per share between $8.10 and $8.20, representing an 8 percent to 9 percent increase. The stock traded at 271.75 euros on November 2, 2026, reflecting investor confidence in the company's execution and long-term growth targets of 12 percent to 15 percent adjusted earnings growth. Investors will closely monitor fourth-quarter execution, the integration pace of the CoolIT acquisition, and the ability to maintain pricing power against inflationary pressures.